Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving the Care Process for Patients with Advanced Prostate CancerRelease Date:Partner: The American Urological Association Education and Research, Inc.; AstellasQuality Improvement Oncology USA Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLCRelease Date:Quality Improvement, Research Oncology Italy Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA 2025 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Research on Disease Burden of CRE (including non-MBL and MBL-CRE), CR-PA and Stenotrophomonas Maltophilia in ChinaRelease Date:Research Hospital China Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC)Release Date:Education Oncology Spain Addressing Barriers to Cancer Care for AIAN and NHPI IndividualsQuality Improvement Oncology USA Title Grant Type Focus Area Country Application Due Date Growth Hormone ResearchRelease Date:Research Rare Disease USA Efforts for early detection of atrial fibrillation and cardioembolic stroke preventionRelease Date:Quality Improvement Internal Medicine Japan Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medicalRelease Date:Education Internal Medicine Japan Patient Registries In ATTR-CMRelease Date:Quality Improvement Rare Disease Japan Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Gene and Anti-TFPI Therapies in HemophiliaRelease Date:Research Rare Disease All Implementing Updated Pneumococcal Immunization Recommendations in AdultsRelease Date:Quality Improvement Vaccines USA Employment support / Lung CancerRelease Date:Education Oncology Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)Release Date:Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast CancerRelease Date:Education Oncology Japan